Capitalmind
Capitalmind
Actionable insights on equities, fixed-income, macros and personal finance Start 14-Days Free Trial
Actionable investing insights Get Free Trial
Premium

Premium: US Investigation Into Price Collusion Haunts Indian Drug Manufacturers

CNX-Pharma-04-November-2016.png

In a major setback for Pharma companies, Bloomberg has confirmed from its sources that U.S. Prosecutors have begun to make headway in the 2 year investigation on generic pharmaceutical companies in relation to suspected price collusion. A clear impact seen in Nifty Pharma which closed 518.30 points or 4.66% down and is currently at levels seen during June on account of Brexit and way back to early . . .

Like our content? Join Capitalmind Premium.

  • Equity, fixed income, macro and personal finance research
  • Model equity and fixed-income portfolios
  • Exclusive apps, tutorials, and member community
Subscribe Now Or start with a free-trial